Disrupt CAD III With the Shockwave Coronary IVL System
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 431 participants.
Also called NCT03595176
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 431 participants
- Sponsor
- Registry
-
NCT03595176
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, France, Germany, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT03595176. Allocation not applicable; no masking; primary purpose treatment. Start 2019-01-09 (actual); primary completion 2020-05-07 (actual). Results posted on 2021-06-21.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Disrupt CAD III With the Shockwave Coronary IVL System
- Condition
- Coronary Artery Disease
- Condition
- Myocardial Infarction
- Intervention (Device)
- Lithotripsy
- Lead sponsor
- Shockwave Medical, Inc.
Record details
- Record id
cardio:ct-nct03595176- Content hash
281c49072aee38639966e88b7af1c9180541ba939cb7fcd7a2572fcd9820ee03